Literature DB >> 23012121

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Organisation.

N Malila1, C Senore, P Armaroli.   

Abstract

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on organisation includes 29 graded recommendations. The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of the screening process, including multi-disciplinary diagnosis and management of the disease. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23012121     DOI: 10.1055/s-0032-1309783

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

2.  Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands.

Authors:  Clasine M de Klerk; Manon van der Vlugt; Bente A Smagge; Esther Toes-Zoutendijk; Iris Lansdorp-Vogelaar; Evelien Dekker; Patrick M Bossuyt
Journal:  Prev Med Rep       Date:  2022-04-05

3.  Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.

Authors:  Yiqing Pan; Lei Zhang; Rongrong Zhang; Jing Han; Wenjun Qin; Yong Gu; Jichen Sha; Xiaoyan Xu; Yi Feng; Zhipeng Ren; Jiawen Dai; Ben Huang; Shifang Ren; Jianxin Gu
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

4.  Increase in the Colorectal Cancer Screening Rate by a Round-Mailed Fecal Immunochemical Testing Kit and Associated Factors in Underserved Regions of Korea: A Community-Based Intervention Study.

Authors:  Seri Hong; Hye Young Shin; Bomyee Lee; Na Rae Hwang; Sang-Hyun Hwang; Jae Kwan Jun
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

5.  The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.

Authors:  Sibel Saya; Jon D Emery; James G Dowty; Jennifer G McIntosh; Ingrid M Winship; Mark A Jenkins
Journal:  JNCI Cancer Spectr       Date:  2020-07-18

6.  Treatment pathways and associated costs of metastatic colorectal cancer in Greece.

Authors:  Ioannis Sougklakos; Elias Athanasiadis; Ioannis Boukovinas; Michalis Karamouzis; Aggelos Koutras; Paulos Papakotoulas; Dimitra Latsou; Magda Hatzikou; Eugena Stamuli; Athanasios Balasopoulos; Aggelos Sideris
Journal:  Cost Eff Resour Alloc       Date:  2022-02-14

7.  Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance.

Authors:  Christian Stock; Bernd Holleczek; Michael Hoffmeister; Thomas Stolz; Christa Stegmaier; Hermann Brenner
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

8.  Is an opportunistic primary care-based intervention for non-responders to bowel screening feasible and acceptable? A mixed-methods feasibility study in Scotland.

Authors:  Natalia Calanzani; Debbie Cavers; Gabriele Vojt; Sheina Orbell; Robert J C Steele; Linda Brownlee; Steve Smith; Julietta Patnick; David Weller; Christine Campbell
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.